Serostim Articles
US FDA to halt breast cancer use for Roche’s Avastin, but EMA says it’s OK in combo with paclitaxel; no immediate somatropin concerns
17 December 2010
Denmark’s Novo Nordisk debuts Victoza in the USA, aiming for $1 billion global sales by 2015
17 February 2010
Japanese Pharma market seeing more foreign entrants
21 January 2010
Ipsen reveals positive findings with rhGH and Increlex
16 September 2009
Global biosimilars product market worth $19.4 billion by 2014
2 September 2009
Sales up 18% in 1st qtr for Novo Nordisk
5 May 2009
Merck KGaA's 1st-qtr profit tumbles 76.3% to 56.7M euros on lower liquid crystal sales
27 April 2009
Sanofi's Apidra SoloSTAR cleared in the USA
9 March 2009
Novo Nordisk profits up 13% on insulin sales
9 February 2009
Ipsen's revenues up 6% on new US launches
9 February 2009
Critical Pharma raises funds to advance pipeline
17 November 2008
FDA clears Sanofi's Apidra for children
3 November 2008
Lantus shows benefits over determir and NPH
15 September 2008
Sandoz gets FDA approval for Omnitrope
8 September 2008
Novo Nordisk's 2nd-qtr 2008 profit falls 32%
18 August 2008
Merck Serono to grow Japanese business
4 August 2008
Levemir comparable to glargine in control and DACON
16 June 2008
66% of Lantus patients meet ADA's 7% target
16 June 2008
Ipsen reports 8.4% sales growth in 1st qtr
12 May 2008
Lilly pulls out of inhaled insulin development
17 March 2008
CHMP recommends Lilly's Forsteo
3 March 2008
Pfizer announces Exubera job cuts; Wyeth may cut workforce 10%
4 February 2008
Ipsen abandons EU NutropinAq application
4 February 2008
Tercica begins dosing in Ph II IGF-1 deficiency trial
4 February 2008
US FDA clears Merck KGaA's easypod
12 November 2007
Ipsen's 9-month sales rise 5.5% to $994.5M
12 November 2007
Novo Nordisk's nine-month profit soars 60%
12 November 2007
Ipsen's six-month net income drops 10%
3 September 2007
Ipsen's 2nd-qtr 2007 sales up 8.1%
13 August 2007
Tercica and Genentech sign R&D deal
16 July 2007
Norditropin gets FDA OK for Noonan syndrome
18 June 2007
Novo Nordisk's 1st-qtr 2007 profit rises 41%
14 May 2007
Pfizer's 1st-qtr profits tumble 17.5%
30 April 2007
No weight gain for "majority" on Levemir
16 April 2007
Novo Nordisk growing in Japan
19 March 2007
Levemir demonstrates safety and efficacy
7 February 2007
Exubera shows safety and efficacy
7 February 2007
Merck Serono debuts easypod injection device
5 February 2007
Mixed results for Novo Nordisk in 3rd-qtr 2006
6 November 2006
Serono's 3rd-qtr 2006 sales rise 8.4% on Rebif
30 October 2006
Eli Lilly PAP approved, patients hit by Part D loophole
9 October 2006
Exubera use not complicated by respiratory infections
25 September 2006
Emerging diabetes management solutions boost European market
14 August 2006
Ipsen's 1st-half 2006 sales rise 7% to $550M
7 August 2006
Pfizer sued by Novo for patent infringement
7 August 2006
Serono's net income up 8% in 2nd-qtr
31 July 2006
Insmed updates on IPLEX launch
13 June 2006
EC grants orphan status to Tercica's Increlex
12 June 2006
Insmed launches Iplex in USA
29 May 2006
Preotact gets EU Marketing approval
1 May 2006
NICE says inhaled insulin "too expensive" for UK, Pfizer appeals to health professionals
24 April 2006
EMEA guidelines on similar biologicals
20 March 2006
US FDA "approvable letter" for NPS' Preos
20 March 2006
Sanofi-Aventis launches Apidra insulin in USA
13 March 2006
Lilly launches Humalog rapid insulin in USA
13 February 2006
Ipsen sees 7.4% sales growth in 2005
13 February 2006
Serono r-hGH meets all Ph III endpoints
16 January 2006
Serono's r-hGH performs well in HARS study
16 January 2006
Tercica launches Increlex in USA
9 January 2006
Insmed shares soar on news of US OD designation for Iplex
19 December 2005
Tercica submits Increlex MAA
19 December 2005
Tercica responds to citizen petition
5 September 2005
FDA OKs Tercica's Increlex for primary IGFD
5 September 2005
Insmed files Citizen Petition to block Tercica's Increlex
22 August 2005
Novo Nordisk debuts GlucaGen HypoKit
18 July 2005
Positive results for Sanofi-Aventis' Lantus
20 June 2005
Tercica moves to block Insmed growth drug in USA
6 June 2005
Priority review for Tercica's growth agent
9 May 2005
Former Serono executives indicted for kickbacks
25 April 2005
One-time provisional charge blights Serono's 1st-qtr results, putting firm into a loss
22 April 2005
Genentech and Ipsen add to existing accord
28 March 2005
Novo Nordisk's Norditropin NordiFlex debuts in USA
31 January 2005
Serono's Saizen also available for adult GHD
17 January 2005
Former Serono sales man pleads guilty to offering US kickbacks
10 January 2005
New use for Novo Nordisk's Norditropin
15 November 2004
Novo Nordisk to appeal court's hGH patent rulings
13 September 2004
FDA clears new delivery device for Aventis' Lantus
23 August 2004
Serono's 2nd-qtr net income jumps 26%
2 August 2004
Serono infertility APIs to be made in Spain
19 July 2004
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
